Brevan Howard Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,952
Closed -$313K 2235
2025
Q4
$313K Sell
2,952
-8,151
-73% -$945K ﹤0.01% 1351
2025
Q3
$1.41M Buy
11,103
+7,071
+175% +$842K 0.01% 741
2025
Q2
$494K Buy
+4,032
New +$461K ﹤0.01% 1358
2025
Q1
Sell
-5,742
Closed -$530K 1240
2024
Q4
$530K Sell
5,742
-3,864
-40% -$379K ﹤0.01% 602
2024
Q3
$928K Buy
+9,606
New +$863K 0.01% 478

Other funds holding EHC

Brevan Howard Capital Management's EHC Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 2,952 shares — an estimated $313K sold.

Brevan Howard Capital Management first reported a position in EHC in Q3 2024 and held it in 5 quarters. The position peaked at $1.41M in Q3 2025. 580 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Brevan Howard Capital Management reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 2,952 Encompass Health shares in Q1 2026, an estimated $313K.
  • Brevan Howard Capital Management first reported a position in Encompass Health in Q3 2024 and held it in 5 quarters.
  • Brevan Howard Capital Management's Encompass Health position peaked at $1.41M in Q3 2025.
  • 580 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.